Literature DB >> 35337359

Brain Injury Biomarkers for Predicting Outcome After Cardiac Arrest.

Jaana Humaloja1, Nicholas J Ashton2, Markus B Skrifvars3.   

Abstract

This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2022. Other selected articles can be found online at https://www.biomedcentral.com/collections/annualupdate2022 . Further information about the Annual Update in Intensive Care and Emergency Medicine is available from https://link.springer.com/bookseries/8901 .
© 2022. Humaloja et al.

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35337359      PMCID： PMC8957160          DOI： 10.1186/s13054-022-03913-5

Source DB:  PubMed          Journal:  Crit Care        ISSN： 1364-8535            Impact factor:   9.097


  50 in total

1.  Plasma tau protein in comatose patients after cardiac arrest treated with therapeutic hypothermia.

Authors:  E Mörtberg; H Zetterberg; J Nordmark; K Blennow; C Catry; H Decraemer; E Vanmechelen; S Rubertsson
Journal:  Acta Anaesthesiol Scand       Date:  2011-09-08       Impact factor: 2.105

2.  S-100B is superior to NSE, BDNF and GFAP in predicting outcome of resuscitation from cardiac arrest with hypothermia treatment.

Authors:  Erik Mörtberg; Henrik Zetterberg; Johanna Nordmark; Kaj Blennow; Lars Rosengren; Sten Rubertsson
Journal:  Resuscitation       Date:  2010-11-10       Impact factor: 5.262

Review 3.  Practice parameter: prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  E F M Wijdicks; A Hijdra; G B Young; C L Bassetti; S Wiebe
Journal:  Neurology       Date:  2006-07-25       Impact factor: 9.910

4.  Neurofilament light chain as an early and sensitive predictor of long-term neurological outcome in patients after cardiac arrest.

Authors:  Obaida R Rana; Jörg W Schröder; Julia K Baukloh; Esra Saygili; Karl Mischke; Johannes Schiefer; Joachim Weis; Nikolaus Marx; Tienush Rassaf; Malte Kelm; Dong-In Shin; Christian Meyer; Erol Saygili
Journal:  Int J Cardiol       Date:  2012-12-31       Impact factor: 4.164

5.  Serum neuron-specific enolase levels from the same patients differ between laboratories: assessment of a prospective post-cardiac arrest cohort.

Authors:  Michael Mlynash; Marion S Buckwalter; Ami Okada; Anna Finley Caulfield; Chitra Venkatasubramanian; Irina Eyngorn; Marcel M Verbeek; Christine A C Wijman
Journal:  Neurocrit Care       Date:  2013-10       Impact factor: 3.210

6.  Combining brain computed tomography and serum neuron specific enolase improves the prognostic performance compared to either alone in comatose cardiac arrest survivors treated with therapeutic hypothermia.

Authors:  Byung Kook Lee; Kyung Woon Jeung; Hyoung Youn Lee; Yong Hun Jung; Dong Hun Lee
Journal:  Resuscitation       Date:  2013-06-17       Impact factor: 5.262

Review 7.  Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.

Authors:  Kaj Blennow; Harald Hampel; Michael Weiner; Henrik Zetterberg
Journal:  Nat Rev Neurol       Date:  2010-02-16       Impact factor: 42.937

8.  Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice.

Authors:  Laurent Ramont; Henri Thoannes; Ariel Volondat; François Chastang; Marie-Christine Millet; François-Xavier Maquart
Journal:  Clin Chem Lab Med       Date:  2005       Impact factor: 3.694

9.  Blood-based biomarkers for prediction of intracranial hemorrhage and outcome in patients with moderate or severe traumatic brain injury.

Authors:  Taylor N Anderson; Jun Hwang; Myrna Munar; Linda Papa; Holly E Hinson; Allison Vaughan; Susan E Rowell
Journal:  J Trauma Acute Care Surg       Date:  2020-07       Impact factor: 3.697

10.  Blood neurofilament light in remote settings: Alternative protocols to support sample collection in challenging pre-analytical conditions.

Authors:  Joel Simrén; Nicholas J Ashton; Kaj Blennow; Henrik Zetterberg
Journal:  Alzheimers Dement (Amst)       Date:  2021-02-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.